NCT05646485Recruiting
Bladder Cancer Screening Trial
Optimal Screening Strategy for Bladder Cancer in at Risk Patients
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 1 Dec 2022
- Start date
- 5 May 2023
- Primary completion date
- Apr 2027
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Bladder cancer
- NCT number
- NCT05646485
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 5 May 2023 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior history of bladder, kidney, or prostate cancer
- Prior evaluation of micro or gross hematuria within the last 2 years
Other
- Do not provide informed consent
Who the study is looking for
- Age ≥ 50
- Smoking: ≥15 pack-year smoking history
- Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.